RM Dafer, M Schneck, TR Friberg, WM Jay - Seminars in Ophthalmology, 2007 - informahealthcare.com Ranibizumab (Lucentis®), a recombinant monoclonal antibody, blocks all active
forms of vascular endothelial growth factor A and was the first treatment for
age-related macular degeneration shown to improve visual acuity in a ... Cited by 24 - Related articles - BL Direct - All 6 versions
- ►prsjournal.com RM Klein, RB Klein - Retina, 2007 - journals.lww.com There is controversy over the use of ranibizumab (Lucentis; Genentech, Inc.,
South San Francisco, CA) and bevacizumab (Avastin; Genentech, Inc.) for treating
wet age-related macular degeneration (AMD), the leading cause of blindness ... Cited by 7 - Related articles - BL Direct - All 3 versions
B Khamar - Indian Journal of Ophthalmology, 2007 - pubmedcentral.nih.gov Off-label (unlabelled or unapproved) use of an approved product refers to the
use of an approved product in a scenario that is not included or is disclaimed
in the product information. Examples include use for a different ... Cited by 2 - Related articles - BL Direct - All 4 versions
NV Chong, T Adewoyin - Eye, 2007 - nature.com Jump to main content; Jump to navigation; nature.com homepage; Publications AZ index;
Browse by subject. My account; Submit manuscript; Register; Subscribe; RCOphth ... Cited by 2 - Related articles - BL Direct - All 4 versions
- ►prsjournal.com D Wong, KKW Li - British Journal of Ophthalmology, 2008 - bjo.bmj.com There are a growing number of publications supporting the use of Avastin
(bevacizumab) for choroidal neovascularisation (CNV) secondary to pathological
myopia (table 1).1 – 8 In this issue, Arias et al (see page 1035) ... Cited by 1 - Related articles - All 4 versions
AB PharmD, RP MD - Journal of Clinical Pharmacy and Therapeutics - interscience.wiley.com The off-label use of drugs is very common in cancer treatment for many reasons.
This practice is challenging for pharmacists who practice in oncology, for
bureaucratic and medico-legal reasons and for reasons concerning ethics. ... Related articles
IDAAPO TRATAMENTO, MRÀI DA … - bvsms.saude.gov.br A degeneração macular relacionada à idade (DMRI) é uma doença ocular
caracterizada pelo dano à mácula. Quando há lesão na mácula, a região
central das imagens é bloqueada, ocorrendo perda progressiva da visão ... Related articles - View as HTML - All 10 versions